Owlet Inc is a company that specializes in developing innovative health monitoring solutions for infants and young children. Its flagship product is a smart sock that uses pulse oximetry technology to measure vital signs such as heart rate and oxygen levels while babies sleep, providing parents with real-time insights and alerts through a mobile app. With a focus on enhancing parental peace of mind, Owlet aims to improve baby health and safety with its advanced monitoring devices and supportive resources, fostering a healthier environment for families. Read More
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced the pricing of an underwritten public offering of 4,196,000 shares of the Company’s Class A common stock (the “Offering”). The shares of Class A common stock are being sold at a public offering price of $7.15 per share, before underwriting discounts and commissions. All of the shares in the Offering are to be sold by the Company. The gross proceeds to Owlet from the Offering are expected to be approximately $30.0 million, before deducting underwriting discounts and commissions and other offering expenses. The Company has granted the underwriters of the Offering a 30-day option to purchase up to an additional 629,400 shares of Class A common stock at the public offering price less the underwriting discounts and commissions. The Offering is expected to close on or about October 23, 2025, subject to the satisfaction of customary closing conditions.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a proposed underwritten public offering of its Class A common stock (the “Offering”). In addition, Owlet intends to grant the underwriters a 30-day option to purchase additional shares of its Class A common stock in an amount up to 15% of the shares offered in the Offering, at the public offering price per share less underwriting discounts and commissions. All of the shares in the Offering are being offered by Owlet.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces that the Central Drugs Standard Control Organization (CDSCO) approved Dream Sock® for distribution. This marks a significant milestone for the Company as it now prepares to launch its integrated monitoring devices, including Dream Sock®, Dream Sight™, and Dream Duo™, across India in early 2026.
Owlet, Inc. (NYSE: OWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, today announced that on September 30, 2025, the Compensation Committee of its Board of Directors approved an equity inducement award to Jordan Thompson, the Company’s Vice President and Corporate Controller. The award was made in connection with Mr. Thompson joining the Company as a material inducement to employment.
Owlet, Inc. (NYSE: OWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, announces the launch of its new HD video baby monitor, Dream Sight™, and next-generation Dream Duo™. These products represent an important step for Owlet in the category, featuring advanced technology designed to provide clarity, connection, and peace of mind from day one.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, this groundbreaking product enables parents to track Baby’s live vital signs and receive real-time health notifications, delivering greater peace of mind.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces that Dream Sock™ has received official certification from Australia’s Therapeutic Goods Administration (TGA), meeting rigorous standards required for medical devices in the region.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2025. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business and corporate update today, August 7, 2025, at 4:30 p.m. ET.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced an agreement with a majority of the holders of the Company’s Series A and Series B warrants to exchange their warrants for common stock.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) plans to announce second quarter 2025 financial results after market close on Thursday, August 7, 2025. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, has donated 250 of its FDA-cleared Dream Sock® smart baby monitors (value equivalent to $75,000) to March of Dimes’ Neonatal Intensive Care Unit (NICU) Care Package Kit program.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2025. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, May 8, 2025, at 4:30 p.m. ET.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) plans to announce first quarter 2025 financial results after market close on Thursday, May 8, 2025. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update.
Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the fourth quarter and full year ended December 31, 2024. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, March 4, 2025, at 4:30 p.m. ET.
